Related references
Note: Only part of the references are listed.Second primary malignancies in multiple myeloma: A review
Christina Poh et al.
BLOOD REVIEWS (2021)
Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma
Gudbjorg Jonsdottir et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
The mutagenic impact of melphalan in multiple myeloma
Francesco Maura et al.
LEUKEMIA (2021)
Second malignancies in multiple myeloma; emerging patterns and future directions
Kylee Maclachlan et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2020)
Second primary malignancy after multiple myeloma-population trends and cause-specific mortality
Luciano J. Costa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis
Philip L. McCarthy et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study
Gudbjorg Jonsdottir et al.
BLOOD ADVANCES (2017)
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years
Monika Engelhardt et al.
HAEMATOLOGICA (2015)
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years
Monika Engelhardt et al.
HAEMATOLOGICA (2015)
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Monika Engelhardt et al.
HAEMATOLOGICA (2014)
Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data
Antonio Palumbo et al.
LANCET ONCOLOGY (2014)
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
A. Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma
Luciano J. Costa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics
P. Razavi et al.
BLOOD CANCER JOURNAL (2013)
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Michel Attal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Myeloma and Second Primary Cancers
Ola Landgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Share Paper
